Automated Compounding Devices Market

DelveInsight’s ‘Automated Compounding Devices (Oncology) (ACD) -Market Insights, Competitive Landscape and Market Forecast-2026’ report delivers an in-depth understanding of automated compounding devices (oncology) and the historical and forecasted automated compounding devices (oncology) market trends in the US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.


The Automated Compounding Devices (Oncology) market report provides an overview of ACD (Oncology), applications of ACD (Oncology) as well as its PEST Analysis. Additionally, the report provides insight on the ACD (Oncology) market share of the individual ACD devices, current and forecasted ACD (Oncology) market size from 2018 to 2026 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.

Automated Compounding Devices (Oncology) Overview

The automated compound devices (ACD) helps in combining several drug solutions to a common container for final administration of the drug within the patient. It helps to eliminate the manual errors and involves the use of computerized algorithms in preparation of the cytotoxic drugs, considering risks associated with the handling of carcinogens for prolonged periods of time, and the extremely personalized treatment in case of cancer patients further increases the chances of an error.


The technology used in ACD comprises of two main methods namely, the gravimetric method and the volumetric methods. Additionally, chemotherapeutic drugs involved are sometimes highly toxic, with a low therapeutic index making it a necessity to prepare the drugs with high precision. The accuracy of these ACD is dependent proportionally on the volume that has to be transferred indicating the higher the volume, more will be the accuracy of the device. Therefore, manufacturers offer a range of volumes that can be transferred, fulfilling the needs of an entire range of customers. The devices are deployed in both hospital settings and pharmacies, measuring powders and liquid component both.


Study Period: 2018–2026

Geography Covered

  • The US
  • EU5 (Germany, France, Italy, Spain and the United Kingdom)
  • Japan

List of Companies:

  • Comecer
  • Arxium
  • Loccioni
  • ICU Medical
  • Omnicell Inc
  • Baxter Healthcare Corporation
  • Grifols International
  • S.A., Equashield
  • B. Braun Medical Inc.

Automated Compounding Devices (Oncology)- Competitive Analysis

This segment of the report provides a brief competitive analysis of Automated Compounding Devices, to help understand the competition in the market. It gives a comparative understanding of the products based on product type.

Automated Compounding Devices (Oncology): Market Segmentation

By Type

  • Macro Automated Compounding Systems
  • Micro Automated Compounding Systems
  • Macro/Micro Automated Compounding Systems


By End-User

  • Hospitals
  • Chemotherapy Centers
  • Pharmacies


By Technology

  • Gravimetric Automated Compounding Systems
  • Volumetric Automated Compounding Systems

Automated Compounding Devices (Oncology): Market Dynamics

Market Drivers

  • The growth of ACD market is driven by an increasing need to reduce the medicinal errors.
  • Increasing interest of cancer patients in the field of personalized medicines and chemotherapy.
  • The cost incurred at the hospitals per dose is reduced and elimination of contamination while compounding solutions are some major advantages that can help in shaping the ACD market.


Market Barriers

  • Higher buying and installation cost for the ACD devices are strict regulations pertaining to the ACD are some of the barriers that can obstruct the propelling growth of the ACD market.
  • Lack of proper reimbursements can obstruct the propelling growth of the ACD market.

Automated Compounding Devices (Oncology): Market Analysis

This segment illustrates the market of Automated Compounding Devices (Oncology) across the 7MM and how the market is expected to rise in the study period (2018 to 2026), at a significant CAGR.

KOL- Views

To keep up with the market trends, we take KOLs and SME’s opinion working in Automated Compounding Devices (Oncology) domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Automated Compounding Devices (Oncology) market trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.

Scope of the Report

  • The report covers the descriptive overview of Automated Compounding Devices (Oncology), explaining its applications, advantages, and limitations, etc.
  • Additionally, an all-inclusive account of the currently available Automated Compounding Devices (Oncology) is provided, which will have an impact on the future market of Automated Compounding Devices (Oncology).
  • A detailed review of Automated Compounding Devices (Oncology) market; historical and forecasted market size is included in the report, covering devices outreach in the 7MM.
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the Automated Compounding Devices (Oncology) market.

Report Highlights

  • The report covers descriptive overview of the Automated Compounding Devices (Oncology), explaining its applications, working mechanism, etc.
  • The report is a comprehensive account of marketed devices present in the Automated Compounding Devices (Oncology) market.
  • The report also reviews the detailed global historical and forecasted Automated Compounding Devices (Oncology) devices market including assessing the outreach in 7 MM.
  • The report helps in developing business strategies by understanding trends shaping and driving the Automated Compounding Devices (Oncology) market.

Automated Compounding Devices (Oncology) Report Key Strengths

  • 6 Years Forecast
  • 7MM Coverage
  • Competitive Landscape
  • Market Size
  • PEST Analysis

Automated Compounding Devices (Oncology) Report Assessment

  • Marketed Product profiles
  • Key Products and Key Players
  • Market Drivers and Barriers
  • Market Forecast
  • KOL’S views

Key Questions

Market Insights:

  • What was the Automated Compounding Devices (Oncology) market share (%) distribution in 2018 and how it will look like in 2026?
  • What will be the Automated Compounding Devices (Oncology) total market size as well as market size by devices across the 7MM during the forecast period (2018–2026)?
  • What are the key findings pertaining to the market across 7MM and which country will have the largest Automated Compounding Devices (Oncology) market Size during the forecast period (2018–2026)?
  • At what CAGR, the Automated Compounding Devices (Oncology) market is expected to grow in 7MM market during the forecast period (2018–2026)?
  • What will be the Automated Compounding Devices (Oncology) market outlook across the 7MM market during the forecast period (2018–2026)?
  • What will be the Automated Compounding Devices (Oncology) market growth till 2026 and what will be the resultant market Size in the year 2026?
  • How will the market drivers, barriers and future opportunities affect the market dynamics and a subsequent analysis of the associated trends?


Competitive Landscape:

  • What are the current devices available in the Automated Compounding Devices (Oncology) market?
  • What is the Automated Compounding Devices (Oncology) available in the market, their product description, regulatory milestones, product development activities, research and development activities etc.?
  • How many key players are developing Automated Compounding Devices (Oncology)?
  • What are the key collaborations (Industry–Industry), mergers and acquisitions, licensing activities related to the Automated Compounding Devices (Oncology)?
  • What are the key designations that have been granted for the current Automated Compounding Devices (Oncology)?
  • What are the global historical and forecasted market of Automated Compounding Devices (Oncology)?

1. Key Insights

2. Executive Summary of Automated Compounding Devices (Oncology)

3. Automated Compounding Devices (Oncology): Background and Overview

3.1. Introduction

4. Automated Compounding Devices (Oncology): Regulatory Scenario

5. Automated Compounding Devices (Oncology): Reimbursement Scenario

6. Company Profiles

6.1. Comecer

6.1.1. Company Overview

6.1.2. Product Portfolio

6.1.2.1. Product Description

6.1.2.2. Regulatory Milestones

6.1.2.3. Research and Development

6.1.2.4. Product Development Activities

6.2. Arxium

6.2.1. Company Overview

6.2.2. Product Portfolio

6.2.2.1. Product Description

6.2.2.2. Regulatory Milestones

6.2.2.3. Research and Development

6.2.2.4. Product Development Activities

Products detail in the report…

7. Intracranial Stents: Competitive Analysis

8. KOL Views

9. Intracranial Stents: Market Analysis in 7MM       

9.1. Intracranial Stents: Market Analysis in 7MM by Type (2018–2026)

9.2. Intracranial Stents: Market Analysis in 7MM by End-user (2018–2026)

9.3. Intracranial Stents: Market Analysis n 7MM by Technology (2018–2026)

10. Country-Wise Market size of Intracranial Stents in 7MM (2018–2026)

10.1. Market size of Intracranial Stents in the United States

10.1.1. Intracranial Stents: Market Analysis in the United State by Type (2018–2026)

10.1.2. Intracranial Stents: Market Analysis in the United State by End-user (2018–2026)

10.1.3. Intracranial Stents: Market Analysis in the United State by Technology (2018–2026)

10.2. Market size of Intracranial Stents in France

10.2.1. Intracranial Stents: Market Analysis in France by Type (2018–2026)

10.2.2. Intracranial Stents: Market Analysis in France by End-user (2018–2026)

10.2.3. Intracranial Stents: Market Analysis in France by Technology (2018–2026)

10.3. Market size of Intracranial Stents in Italy

10.3.1. Intracranial Stents: Market Analysis in Italy by Type (2018–2026)

10.3.2. Intracranial Stents: Market Analysis in Italy by End-user (2018–2026)

10.3.3. Intracranial Stents: Market Analysis in Italy by Technology (2018–2026)

10.4. Market size of Intracranial Stents in the UK

10.4.1. Intracranial Stents: Market Analysis in the UK by Type (2018–2026)

10.4.2. Intracranial Stents: Market Analysis in the UK by End-user (2018–2026)

10.4.3. Intracranial Stents: Market Analysis in the UK by Technology (2018–2026)

10.5. Market size of Intracranial Stents in Spain

10.5.1. Intracranial Stents: Market Analysis in Spain by Type (2018–2026)

10.5.2. Intracranial Stents: Market Analysis in Spain by End-user (2018–2026)

10.5.3. Intracranial Stents: Market Analysis in Spain by Technology (2018–2026)

10.6. Market size of Intracranial Stents in Germany

10.6.1. Intracranial Stents: Market Analysis in Germany by Type (2018–2026)

10.6.2. Intracranial Stents: Market Analysis in Germany by End-user (2018–2026)

10.6.3. Intracranial Stents: Market Analysis in Germany by Technology (2018–2026)

10.7. Market size of Intracranial Stents in Japan

10.7.1. Intracranial Stents: Market Analysis in Japan by Type (2018–2026)

10.7.2. Intracranial Stents: Market Analysis in Japan by End-user (2018–2026)

10.7.3. Intracranial Stents: Market Analysis in Japan by Technology (2018–2026)       

11. Market Dynamic

11.1. Market Drivers

11.2. Market Barriers

12. PEST Analysis

13. Conclusion and Future Perspective

14. Appendix

14.1. Bibliography

14.2. Report Methodology

15. DelveInsight Capabilities

16. Disclaimer

17. About DelveInsight

List of Table

Table 1: Competitive Analysis

Table 2: Automated Compounding Devices Market Analysis in the 7MM (2018–2026)

Table 3: Automated Compounding Devices Market Analysis in the 7MM by type (2018–2026)

Table 4: Automated Compounding Devices Market Analysis in the 7MM by technology (2018–2026)

Table 5: Automated Compounding Devices Market Analysis in the 7MM by end user (2018–2026)

Table 6: Automated Compounding Devices in the US Market Analysis (2018–2026)

Table 7: Automated Compounding Devices Market Analysis in the US by type (2018-2026)

Table 8: Automated Compounding Devices Market Analysis in the US by technology (2018-2026)

Table 9: Automated Compounding Devices Market Analysis in the US by end user (2018-2026)

Table 10: Automated Compounding Devices Market Analysis in Germany (2018–2026)

Table 11: Automated Compounding Devices Market Analysis in Germany by type (2018-2026)

Table 12: Automated Compounding Devices Market Analysis in Germany by technology (2018-2026)

Table 13: Automated Compounding Devices Market Analysis in Germany by end user (2018-2026)

Table 14: Automated Compounding Devices Market Analysis in France (2018–2026)

Table 15: Automated Compounding Devices Market Analysis in France by type (2018-2026)

Table 16: Automated Compounding Devices Market Analysis in France by technology (2018–2026)

Table 17: Automated Compounding Devices Market Analysis in France by end user (2018–2026)

Table 18: Automated Compounding Devices Market Analysis in Spain (2018–2026)

Table 19: Automated Compounding Devices Market Analysis in Spain by type (2018–2026)

Table 20: Automated Compounding Devices Market Analysis in Spain by technology (2018–2026)

Table 21: Automated Compounding Devices Market Analysis in Spain by end user (2018–2026)

Table 22: Automated Compounding Devices Market Analysis in Italy (2018–2026)

Table 23: Automated Compounding Devices Market Analysis in Italy by type (2018–2026)

Table 24: Automated Compounding Devices Market Analysis in Italy by technology (2018–2026)

Table 25: Automated Compounding Devices Market Analysis in Italy by end user (2018–2026)

Table 26: Automated Compounding Devices Market Analysis in the United Kingdom (2018–2026)

Table 27: Automated Compounding Devices Market Analysis in the United Kingdom by type (2018–2026)

Table 28: Automated Compounding Devices Market Analysis in the United Kingdom by technology (2018–2026)

Table 29: Automated Compounding Devices Market Analysis in the United Kingdom by end user (2018–2026)

Table 30: Automated Compounding Devices Market Analysis in Japan (2018–2026)

Table 31: Automated Compounding Devices Market Analysis in Japan by type (2018–2026)

Table 32: Automated Compounding Devices Market Analysis in Japan by technology (2018–2026)

Table 33: Automated Compounding Devices Market Analysis in Japan by end user (2018–2026)

List of Figures

Figure 1: Product description of Automated Compounding Devices

Figure 2: Automated Compounding Devices Market Analysis in the 7MM (2018–2026)

Figure 3: Automated Compounding Devices Market Analysis in the 7MM by type (2018–2026)

Figure 4: Automated Compounding Devices Market Analysis in the 7MM by technology (2018–2026)

Figure 5: Automated Compounding Devices Market Analysis in the 7MM by end user (2018–2026)

Figure 6: Automated Compounding Devices in the US (2018–2026)

Figure 7: Automated Compounding Devices Market Analysis in the US by type (2018-2026)

Figure 8: Automated Compounding Devices Market Analysis in the US by technology (2018-2026)

Figure 9: Automated Compounding Devices Market Analysis in the US by end user (2018-2026)

Figure 10: Automated Compounding Devices Market Analysis in Germany (2018–2026)

Figure 11: Automated Compounding Devices Market Analysis in Germany by type (2018-2026)

Figure 12: Automated Compounding Devices Market Analysis in Germany by technology (2018-2026)

Figure 13: Automated Compounding Devices Market Analysis in Germany by end user (2018-2026)

Figure 14: Automated Compounding Devices Market Analysis in France (2018–2026)

Figure 15: Automated Compounding Devices Market Analysis in France by type (2018–2026)

Figure 16: Automated Compounding Devices Market Analysis in France by technology (2018–2026)

Figure 17: Automated Compounding Devices Market Analysis in France by end user (2018–2026)

Figure 18: Automated Compounding Devices Market Analysis in Spain (2018–2026)

Figure 19: Automated Compounding Devices Market Analysis in Spain by type (2018–2026)

Figure 20: Automated Compounding Devices Market Analysis in Spain by technology (2018–2026)

Figure 21: Automated Compounding Devices Market Analysis in Spain by end user (2018–2026)

Figure 22: Automated Compounding Devices Market Analysis in Italy (2018–2026)

Figure 23: Automated Compounding Devices Market Analysis in Italy by type (2018–2026)

Figure 24: Automated Compounding Devices Market Analysis in Italy by technology (2018–2026)

Figure 25: Automated Compounding Devices Market Analysis in Italy by end user (2018–2026)

Figure 26: Automated Compounding Devices Market Analysis in United Kingdom (2018–2026)

Figure 27: Automated Compounding Devices Market Analysis in the United Kingdom by type (2018–2026)

Figure 28: Automated Compounding Devices Market Analysis in the United Kingdom by technology (2018–2026)

Figure 29: Automated Compounding Devices Market Analysis in the United Kingdom by end user (2018–2026)

Figure 30: Automated Compounding Devices Market Analysis in Japan (2018–2026)

Figure 31: Automated Compounding Devices Market Analysis in Japan by type (2018–2026)

Figure 32: Automated Compounding Devices Market Analysis in Japan by technology (2018–2026)

Figure 33: Automated Compounding Devices Market Analysis in Japan by end user (2018–2026)

Figure 34: Market Drivers

Figure 35: Market Barriers

Comecer

Arxium

Loccioni

ICU Medical

Omnicell Inc

Baxter Healthcare Corporation

Grifols International

S.A., Equashield

B. Braun Medical Inc.

  • Tags:
  • Automated Compounding Devices
  • Automated Compounding Devices Mech...
  • Automated Compounding Devices Comp...
  • Automated Compounding Devices Medi...
  • Automated Compounding Devices Mark...
  • Automated Compounding Devices Indu...

Forward to Friend

Need A Quote